LFCR
Lifecore Biomedical Inc.
4.20$
-2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.9% | 4.0% | 5.5% | 3.8% | 2.9% | -10.6% | 16.3% | -13.1% | -20.3% | 0.2% | -0.2% | 9.7% | |
| 1.3% | 1.7% | 2.0% | 2.4% | 2.7% | 11.8% | 19.7% | 9.6% | 16.2% | 6.2% | 6.2% | 5.3% | |
| 0.3% | 0.6% | 0.7% | 0.8% | 0.6% | 0.0% | 3.3% | 1.4% | 2.3% | 4.8% | 7.9% | 4.8% | |
| – | – | – | – | 0.4% | 18.5% | 18.8% | 33.2% | 28.9% | – | – | – | |
| 0.6% | -0.5% | 0.1% | -1.9% | -0.2% | -17.3% | 9.7% | -3.6% | -2.8% | -2.9% | -3.6% | -1.8% | |
| 3.2% | 7.6% | 4.2% | 6.4% | 8.0% | 16.7% | 25.0% | 15.1% | 26.9% | 14.3% | 10.4% | 4.9% | |
| -6.4% | -7.7% | -4.7% | -6.8% | -17.4% | -14.9% | -12.2% | 44.0% | 71.9% | -14.3% | -5.0% | -1.3% | |
| – | – | – | – | 0.1% | 0.1% | – | – | 0.2% | 2.4% | – | – | |
| -0.1% | – | -0.1% | -0.3% | -0.1% | -0.1% | -0.4% | – | -0.7% | -0.1% | – | -1.5% | |
| – | – | – | – | 14.3% | 26.1% | 7.4% | -29.8% | 17.4% | 1.7% | -12.2% | – | |
| 1.5% | 2.9% | -1.7% | 2.5% | 14.2% | 25.0% | -3.4% | -30.7% | -51.2% | 5.9% | 5.0% | -0.9% | |
| 0.0% | -0.8% | -0.8% | -0.5% | -0.3% | -0.6% | 0.7% | 0.2% | 0.3% | -8.3% | -0.2% | -0.2% | |
| 1.6% | -3.5% | 1.3% | -2.6% | -5.1% | -27.3% | -8.7% | -28.3% | -47.2% | -14.1% | -10.6% | 4.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.